According to new survey, global Recombinant Human Growth Hormone market is projected to reach US$ 7400.2 million in 2029, increasing from US$ 4268 million in 2022, with the CAGR of 8.2% during the period of 2023 to 2029.

Recombinant Human Growth Hormone Market

Recombinant human growth hormone is produced by gene recombinant Escherichia coli secretory expression technology, and it is completely consistent with human pituitary growth hormone in amino acid content, sequence and protein structure. In the field of pediatrics, replacement therapy with recombinant human growth hormone can significantly promote children's height growth and improve the growth and development of various organs and tissues throughout the body. At the same time, recombinant human growth hormone also plays an important role in the fields of reproduction, burns and anti-aging.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Recombinant Human Growth Hormone market research.

Key manufacturers engaged in the Recombinant Human Growth Hormone industry include Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck Serono, F.Hoffmann-La Roche, Ispen, Sandoz International and Changchun High-Tech Industries, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Recombinant Human Growth Hormone were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Recombinant Human Growth Hormone market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Recombinant Human Growth Hormone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Recombinant Human Growth Hormone Market Report

Report Metric	Details
Report Name	Recombinant Human Growth Hormone Market
Accounted market size in 2022	US$ 4268 million
Forecasted market size in 2029	US$ 7400.2 million
CAGR	8.2%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Powder Injection Water Injection
Segment by Application	Childhood Growth Hormone Deficiency Chronic Renal Insufficiency HIV Infection-Associated Wasting Syndrome Adult GHD Replacement Therapy Small For Gestational Age (SGA) Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck Serono, F.Hoffmann-La Roche, Ispen, Sandoz International, Changchun High-Tech Industries, Shenzhen Kexing Pharmaceutical, Changchun GeneScience Pharmaceutical, Anhui Anke Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Recombinant Human Growth Hormone Market growing?

Ans: The Recombinant Human Growth Hormone Market witnessing a CAGR of 8.2% during the forecast period 2023-2029.

What is the Recombinant Human Growth Hormone Market size in 2029?

Ans: The Recombinant Human Growth Hormone Market size in 2029 will be US$ 7400.2 million.

Who are the main players in the Recombinant Human Growth Hormone Market report?

Ans: The main players in the Recombinant Human Growth Hormone Market are Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck Serono, F.Hoffmann-La Roche, Ispen, Sandoz International, Changchun High-Tech Industries, Shenzhen Kexing Pharmaceutical, Changchun GeneScience Pharmaceutical, Anhui Anke Biotechnology

What are the Application segmentation covered in the Recombinant Human Growth Hormone Market report?

Ans: The Applications covered in the Recombinant Human Growth Hormone Market report are Childhood Growth Hormone Deficiency, Chronic Renal Insufficiency, HIV Infection-Associated Wasting Syndrome, Adult GHD Replacement Therapy, Small For Gestational Age (SGA), Others

What are the Type segmentation covered in the Recombinant Human Growth Hormone Market report?

Ans: The Types covered in the Recombinant Human Growth Hormone Market report are Powder Injection, Water Injection

1 Recombinant Human Growth Hormone Market Overview

1.1 Product Overview and Scope of Recombinant Human Growth Hormone

1.2 Recombinant Human Growth Hormone Segment by Type

1.2.1 Global Recombinant Human Growth Hormone Market Value Comparison by Type (2023-2029)

1.2.2 Powder Injection

1.2.3 Water Injection

1.3 Recombinant Human Growth Hormone Segment by Application

1.3.1 Global Recombinant Human Growth Hormone Market Value by Application: (2023-2029)

1.3.2 Childhood Growth Hormone Deficiency

1.3.3 Chronic Renal Insufficiency

1.3.4 HIV Infection-Associated Wasting Syndrome

1.3.5 Adult GHD Replacement Therapy

1.3.6 Small For Gestational Age (SGA)

1.3.7 Others

1.4 Global Recombinant Human Growth Hormone Market Size Estimates and Forecasts

1.4.1 Global Recombinant Human Growth Hormone Revenue 2018-2029

1.4.2 Global Recombinant Human Growth Hormone Sales 2018-2029

1.4.3 Global Recombinant Human Growth Hormone Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2 Recombinant Human Growth Hormone Market Competition by Manufacturers

2.1 Global Recombinant Human Growth Hormone Sales Market Share by Manufacturers (2018-2023)

2.2 Global Recombinant Human Growth Hormone Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Recombinant Human Growth Hormone Average Price by Manufacturers (2018-2023)

2.4 Global Recombinant Human Growth Hormone Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Recombinant Human Growth Hormone, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Human Growth Hormone, Product Type & Application

2.7 Recombinant Human Growth Hormone Market Competitive Situation and Trends

2.7.1 Recombinant Human Growth Hormone Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Recombinant Human Growth Hormone Players Market Share by Revenue

2.7.3 Global Recombinant Human Growth Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Recombinant Human Growth Hormone Retrospective Market Scenario by Region

3.1 Global Recombinant Human Growth Hormone Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Recombinant Human Growth Hormone Global Recombinant Human Growth Hormone Sales by Region: 2018-2029

3.2.1 Global Recombinant Human Growth Hormone Sales by Region: 2018-2023

3.2.2 Global Recombinant Human Growth Hormone Sales by Region: 2024-2029

3.3 Global Recombinant Human Growth Hormone Global Recombinant Human Growth Hormone Revenue by Region: 2018-2029

3.3.1 Global Recombinant Human Growth Hormone Revenue by Region: 2018-2023

3.3.2 Global Recombinant Human Growth Hormone Revenue by Region: 2024-2029

3.4 North America Recombinant Human Growth Hormone Market Facts & Figures by Country

3.4.1 North America Recombinant Human Growth Hormone Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Recombinant Human Growth Hormone Sales by Country (2018-2029)

3.4.3 North America Recombinant Human Growth Hormone Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Recombinant Human Growth Hormone Market Facts & Figures by Country

3.5.1 Europe Recombinant Human Growth Hormone Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Recombinant Human Growth Hormone Sales by Country (2018-2029)

3.5.3 Europe Recombinant Human Growth Hormone Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Human Growth Hormone Market Facts & Figures by Country

3.6.1 Asia Pacific Recombinant Human Growth Hormone Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Recombinant Human Growth Hormone Sales by Country (2018-2029)

3.6.3 Asia Pacific Recombinant Human Growth Hormone Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Recombinant Human Growth Hormone Market Facts & Figures by Country

3.7.1 Latin America Recombinant Human Growth Hormone Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Recombinant Human Growth Hormone Sales by Country (2018-2029)

3.7.3 Latin America Recombinant Human Growth Hormone Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Recombinant Human Growth Hormone Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Human Growth Hormone Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Recombinant Human Growth Hormone Sales by Country (2018-2029)

3.8.3 Middle East and Africa Recombinant Human Growth Hormone Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Recombinant Human Growth Hormone Sales by Type (2018-2029)

4.1.1 Global Recombinant Human Growth Hormone Sales by Type (2018-2023)

4.1.2 Global Recombinant Human Growth Hormone Sales by Type (2024-2029)

4.1.3 Global Recombinant Human Growth Hormone Sales Market Share by Type (2018-2029)

4.2 Global Recombinant Human Growth Hormone Revenue by Type (2018-2029)

4.2.1 Global Recombinant Human Growth Hormone Revenue by Type (2018-2023)

4.2.2 Global Recombinant Human Growth Hormone Revenue by Type (2024-2029)

4.2.3 Global Recombinant Human Growth Hormone Revenue Market Share by Type (2018-2029)

4.3 Global Recombinant Human Growth Hormone Price by Type (2018-2029)

5 Segment by Application

5.1 Global Recombinant Human Growth Hormone Sales by Application (2018-2029)

5.1.1 Global Recombinant Human Growth Hormone Sales by Application (2018-2023)

5.1.2 Global Recombinant Human Growth Hormone Sales by Application (2024-2029)

5.1.3 Global Recombinant Human Growth Hormone Sales Market Share by Application (2018-2029)

5.2 Global Recombinant Human Growth Hormone Revenue by Application (2018-2029)

5.2.1 Global Recombinant Human Growth Hormone Revenue by Application (2018-2023)

5.2.2 Global Recombinant Human Growth Hormone Revenue by Application (2024-2029)

5.2.3 Global Recombinant Human Growth Hormone Revenue Market Share by Application (2018-2029)

5.3 Global Recombinant Human Growth Hormone Price by Application (2018-2029)

6 Key Companies Profiled

6.1 Novo Nordisk

6.1.1 Novo Nordisk Corporation Information

6.1.2 Novo Nordisk Description and Business Overview

6.1.3 Novo Nordisk Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Novo Nordisk Recombinant Human Growth Hormone Product Portfolio

6.1.5 Novo Nordisk Recent Developments/Updates

6.2 LG Chem

6.2.1 LG Chem Corporation Information

6.2.2 LG Chem Description and Business Overview

6.2.3 LG Chem Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.2.4 LG Chem Recombinant Human Growth Hormone Product Portfolio

6.2.5 LG Chem Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Pfizer Recombinant Human Growth Hormone Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Eli lilly

6.4.1 Eli lilly Corporation Information

6.4.2 Eli lilly Description and Business Overview

6.4.3 Eli lilly Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Eli lilly Recombinant Human Growth Hormone Product Portfolio

6.4.5 Eli lilly Recent Developments/Updates

6.5 Merck Serono

6.5.1 Merck Serono Corporation Information

6.5.2 Merck Serono Description and Business Overview

6.5.3 Merck Serono Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Merck Serono Recombinant Human Growth Hormone Product Portfolio

6.5.5 Merck Serono Recent Developments/Updates

6.6 F.Hoffmann-La Roche

6.6.1 F.Hoffmann-La Roche Corporation Information

6.6.2 F.Hoffmann-La Roche Description and Business Overview

6.6.3 F.Hoffmann-La Roche Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.6.4 F.Hoffmann-La Roche Recombinant Human Growth Hormone Product Portfolio

6.6.5 F.Hoffmann-La Roche Recent Developments/Updates

6.7 Ispen

6.6.1 Ispen Corporation Information

6.6.2 Ispen Description and Business Overview

6.6.3 Ispen Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Ispen Recombinant Human Growth Hormone Product Portfolio

6.7.5 Ispen Recent Developments/Updates

6.8 Sandoz International

6.8.1 Sandoz International Corporation Information

6.8.2 Sandoz International Description and Business Overview

6.8.3 Sandoz International Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Sandoz International Recombinant Human Growth Hormone Product Portfolio

6.8.5 Sandoz International Recent Developments/Updates

6.9 Changchun High-Tech Industries

6.9.1 Changchun High-Tech Industries Corporation Information

6.9.2 Changchun High-Tech Industries Description and Business Overview

6.9.3 Changchun High-Tech Industries Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Changchun High-Tech Industries Recombinant Human Growth Hormone Product Portfolio

6.9.5 Changchun High-Tech Industries Recent Developments/Updates

6.10 Shenzhen Kexing Pharmaceutical

6.10.1 Shenzhen Kexing Pharmaceutical Corporation Information

6.10.2 Shenzhen Kexing Pharmaceutical Description and Business Overview

6.10.3 Shenzhen Kexing Pharmaceutical Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Shenzhen Kexing Pharmaceutical Recombinant Human Growth Hormone Product Portfolio

6.10.5 Shenzhen Kexing Pharmaceutical Recent Developments/Updates

6.11 Changchun GeneScience Pharmaceutical

6.11.1 Changchun GeneScience Pharmaceutical Corporation Information

6.11.2 Changchun GeneScience Pharmaceutical Recombinant Human Growth Hormone Description and Business Overview

6.11.3 Changchun GeneScience Pharmaceutical Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Changchun GeneScience Pharmaceutical Recombinant Human Growth Hormone Product Portfolio

6.11.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates

6.12 Anhui Anke Biotechnology

6.12.1 Anhui Anke Biotechnology Corporation Information

6.12.2 Anhui Anke Biotechnology Recombinant Human Growth Hormone Description and Business Overview

6.12.3 Anhui Anke Biotechnology Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Anhui Anke Biotechnology Recombinant Human Growth Hormone Product Portfolio

6.12.5 Anhui Anke Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Recombinant Human Growth Hormone Industry Chain Analysis

7.2 Recombinant Human Growth Hormone Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Human Growth Hormone Production Mode & Process

7.4 Recombinant Human Growth Hormone Sales and Marketing

7.4.1 Recombinant Human Growth Hormone Sales Channels

7.4.2 Recombinant Human Growth Hormone Distributors

7.5 Recombinant Human Growth Hormone Customers

8 Recombinant Human Growth Hormone Market Dynamics

8.1 Recombinant Human Growth Hormone Industry Trends

8.2 Recombinant Human Growth Hormone Market Drivers

8.3 Recombinant Human Growth Hormone Market Challenges

8.4 Recombinant Human Growth Hormone Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Anhui Anke Biotechnology

LG Chem

Ispen

Shenzhen Kexing Pharmaceutical

Changchun GeneScience Pharmaceutical

Changchun High-Tech Industries

List of Tables

Table 1. Global Recombinant Human Growth Hormone Market Value Comparison by Type (2023-2029) & (US$ Million)

Table 2. Global Recombinant Human Growth Hormone Market Value Comparison by Application (2023-2029) & (US$ Million)

Table 3. Global Recombinant Human Growth Hormone Market Competitive Situation by Manufacturers in 2022

Table 4. Global Recombinant Human Growth Hormone Sales (K Units) of Key Manufacturers (2018-2023)

Table 5. Global Recombinant Human Growth Hormone Sales Market Share by Manufacturers (2018-2023)

Table 6. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Manufacturers (2018-2023)

Table 7. Global Recombinant Human Growth Hormone Revenue Share by Manufacturers (2018-2023)

Table 8. Global Market Recombinant Human Growth Hormone Average Price (US$/Unit) of Key Manufacturers (2018-2023)

Table 9. Global Key Players of Recombinant Human Growth Hormone, Industry Ranking, 2021 VS 2022 VS 2023

Table 10. Global Key Manufacturers of Recombinant Human Growth Hormone, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Recombinant Human Growth Hormone, Product Type & Application

Table 12. Global Key Manufacturers of Recombinant Human Growth Hormone, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Recombinant Human Growth Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Growth Hormone as of 2022)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Recombinant Human Growth Hormone Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 17. Global Recombinant Human Growth Hormone Sales by Region (2018-2023) & (K Units)

Table 18. Global Recombinant Human Growth Hormone Sales Market Share by Region (2018-2023)

Table 19. Global Recombinant Human Growth Hormone Sales by Region (2024-2029) & (K Units)

Table 20. Global Recombinant Human Growth Hormone Sales Market Share by Region (2024-2029)

Table 21. Global Recombinant Human Growth Hormone Revenue by Region (2018-2023) & (US$ Million)

Table 22. Global Recombinant Human Growth Hormone Revenue Market Share by Region (2018-2023)

Table 23. Global Recombinant Human Growth Hormone Revenue by Region (2024-2029) & (US$ Million)

Table 24. Global Recombinant Human Growth Hormone Revenue Market Share by Region (2024-2029)

Table 25. North America Recombinant Human Growth Hormone Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 26. North America Recombinant Human Growth Hormone Sales by Country (2018-2023) & (K Units)

Table 27. North America Recombinant Human Growth Hormone Sales by Country (2024-2029) & (K Units)

Table 28. North America Recombinant Human Growth Hormone Revenue by Country (2018-2023) & (US$ Million)

Table 29. North America Recombinant Human Growth Hormone Revenue by Country (2024-2029) & (US$ Million)

Table 30. Europe Recombinant Human Growth Hormone Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 31. Europe Recombinant Human Growth Hormone Sales by Country (2018-2023) & (K Units)

Table 32. Europe Recombinant Human Growth Hormone Sales by Country (2024-2029) & (K Units)

Table 33. Europe Recombinant Human Growth Hormone Revenue by Country (2018-2023) & (US$ Million)

Table 34. Europe Recombinant Human Growth Hormone Revenue by Country (2024-2029) & (US$ Million)

Table 35. Asia Pacific Recombinant Human Growth Hormone Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 36. Asia Pacific Recombinant Human Growth Hormone Sales by Region (2018-2023) & (K Units)

Table 37. Asia Pacific Recombinant Human Growth Hormone Sales by Region (2024-2029) & (K Units)

Table 38. Asia Pacific Recombinant Human Growth Hormone Revenue by Region (2018-2023) & (US$ Million)

Table 39. Asia Pacific Recombinant Human Growth Hormone Revenue by Region (2024-2029) & (US$ Million)

Table 40. Latin America Recombinant Human Growth Hormone Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 41. Latin America Recombinant Human Growth Hormone Sales by Country (2018-2023) & (K Units)

Table 42. Latin America Recombinant Human Growth Hormone Sales by Country (2024-2029) & (K Units)

Table 43. Latin America Recombinant Human Growth Hormone Revenue by Country (2018-2023) & (US$ Million)

Table 44. Latin America Recombinant Human Growth Hormone Revenue by Country (2024-2029) & (US$ Million)

Table 45. Middle East & Africa Recombinant Human Growth Hormone Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 46. Middle East & Africa Recombinant Human Growth Hormone Sales by Country (2018-2023) & (K Units)

Table 47. Middle East & Africa Recombinant Human Growth Hormone Sales by Country (2024-2029) & (K Units)

Table 48. Middle East & Africa Recombinant Human Growth Hormone Revenue by Country (2018-2023) & (US$ Million)

Table 49. Middle East & Africa Recombinant Human Growth Hormone Revenue by Country (2024-2029) & (US$ Million)

Table 50. Global Recombinant Human Growth Hormone Sales (K Units) by Type (2018-2023)

Table 51. Global Recombinant Human Growth Hormone Sales (K Units) by Type (2024-2029)

Table 52. Global Recombinant Human Growth Hormone Sales Market Share by Type (2018-2023)

Table 53. Global Recombinant Human Growth Hormone Sales Market Share by Type (2024-2029)

Table 54. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Type (2018-2023)

Table 55. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Type (2024-2029)

Table 56. Global Recombinant Human Growth Hormone Revenue Market Share by Type (2018-2023)

Table 57. Global Recombinant Human Growth Hormone Revenue Market Share by Type (2024-2029)

Table 58. Global Recombinant Human Growth Hormone Price (US$/Unit) by Type (2018-2023)

Table 59. Global Recombinant Human Growth Hormone Price (US$/Unit) by Type (2024-2029)

Table 60. Global Recombinant Human Growth Hormone Sales (K Units) by Application (2018-2023)

Table 61. Global Recombinant Human Growth Hormone Sales (K Units) by Application (2024-2029)

Table 62. Global Recombinant Human Growth Hormone Sales Market Share by Application (2018-2023)

Table 63. Global Recombinant Human Growth Hormone Sales Market Share by Application (2024-2029)

Table 64. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Application (2018-2023)

Table 65. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Application (2024-2029)

Table 66. Global Recombinant Human Growth Hormone Revenue Market Share by Application (2018-2023)

Table 67. Global Recombinant Human Growth Hormone Revenue Market Share by Application (2024-2029)

Table 68. Global Recombinant Human Growth Hormone Price (US$/Unit) by Application (2018-2023)

Table 69. Global Recombinant Human Growth Hormone Price (US$/Unit) by Application (2024-2029)

Table 70. Novo Nordisk Corporation Information

Table 71. Novo Nordisk Description and Business Overview

Table 72. Novo Nordisk Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 73. Novo Nordisk Recombinant Human Growth Hormone Product

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. LG Chem Corporation Information

Table 76. LG Chem Description and Business Overview

Table 77. LG Chem Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 78. LG Chem Recombinant Human Growth Hormone Product

Table 79. LG Chem Recent Developments/Updates

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 83. Pfizer Recombinant Human Growth Hormone Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Eli lilly Corporation Information

Table 86. Eli lilly Description and Business Overview

Table 87. Eli lilly Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 88. Eli lilly Recombinant Human Growth Hormone Product

Table 89. Eli lilly Recent Developments/Updates

Table 90. Merck Serono Corporation Information

Table 91. Merck Serono Description and Business Overview

Table 92. Merck Serono Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 93. Merck Serono Recombinant Human Growth Hormone Product

Table 94. Merck Serono Recent Developments/Updates

Table 95. F.Hoffmann-La Roche Corporation Information

Table 96. F.Hoffmann-La Roche Description and Business Overview

Table 97. F.Hoffmann-La Roche Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 98. F.Hoffmann-La Roche Recombinant Human Growth Hormone Product

Table 99. F.Hoffmann-La Roche Recent Developments/Updates

Table 100. Ispen Corporation Information

Table 101. Ispen Description and Business Overview

Table 102. Ispen Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 103. Ispen Recombinant Human Growth Hormone Product

Table 104. Ispen Recent Developments/Updates

Table 105. Sandoz International Corporation Information

Table 106. Sandoz International Description and Business Overview

Table 107. Sandoz International Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 108. Sandoz International Recombinant Human Growth Hormone Product

Table 109. Sandoz International Recent Developments/Updates

Table 110. Changchun High-Tech Industries Corporation Information

Table 111. Changchun High-Tech Industries Description and Business Overview

Table 112. Changchun High-Tech Industries Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 113. Changchun High-Tech Industries Recombinant Human Growth Hormone Product

Table 114. Changchun High-Tech Industries Recent Developments/Updates

Table 115. Shenzhen Kexing Pharmaceutical Corporation Information

Table 116. Shenzhen Kexing Pharmaceutical Description and Business Overview

Table 117. Shenzhen Kexing Pharmaceutical Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 118. Shenzhen Kexing Pharmaceutical Recombinant Human Growth Hormone Product

Table 119. Shenzhen Kexing Pharmaceutical Recent Developments/Updates

Table 120. Changchun GeneScience Pharmaceutical Corporation Information

Table 121. Changchun GeneScience Pharmaceutical Description and Business Overview

Table 122. Changchun GeneScience Pharmaceutical Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 123. Changchun GeneScience Pharmaceutical Recombinant Human Growth Hormone Product

Table 124. Changchun GeneScience Pharmaceutical Recent Developments/Updates

Table 125. Anhui Anke Biotechnology Corporation Information

Table 126. Anhui Anke Biotechnology Description and Business Overview

Table 127. Anhui Anke Biotechnology Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 128. Anhui Anke Biotechnology Recombinant Human Growth Hormone Product

Table 129. Anhui Anke Biotechnology Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Recombinant Human Growth Hormone Distributors List

Table 133. Recombinant Human Growth Hormone Customers List

Table 134. Recombinant Human Growth Hormone Market Trends

Table 135. Recombinant Human Growth Hormone Market Drivers

Table 136. Recombinant Human Growth Hormone Market Challenges

Table 137. Recombinant Human Growth Hormone Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Recombinant Human Growth Hormone

Figure 2. Global Recombinant Human Growth Hormone Market Value Comparison by Type (2023-2029) & (US$ Million)

Figure 3. Global Recombinant Human Growth Hormone Market Share by Type in 2022 & 2029

Figure 4. Powder Injection Product Picture

Figure 5. Water Injection Product Picture

Figure 6. Global Recombinant Human Growth Hormone Market Value Comparison by Application (2023-2029) & (US$ Million)

Figure 7. Global Recombinant Human Growth Hormone Market Share by Application in 2022 & 2029

Figure 8. Childhood Growth Hormone Deficiency

Figure 9. Chronic Renal Insufficiency

Figure 10. HIV Infection-Associated Wasting Syndrome

Figure 11. Adult GHD Replacement Therapy

Figure 12. Small For Gestational Age (SGA)

Figure 13. Others

Figure 14. Global Recombinant Human Growth Hormone Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Recombinant Human Growth Hormone Market Size (2018-2029) & (US$ Million)

Figure 16. Global Recombinant Human Growth Hormone Sales (2018-2029) & (K Units)

Figure 17. Global Recombinant Human Growth Hormone Average Price (US$/Unit) & (2018-2029)

Figure 18. Recombinant Human Growth Hormone Report Years Considered

Figure 19. Recombinant Human Growth Hormone Sales Share by Manufacturers in 2022

Figure 20. Global Recombinant Human Growth Hormone Revenue Share by Manufacturers in 2022

Figure 21. The Global 5 and 10 Largest Recombinant Human Growth Hormone Players: Market Share by Revenue in 2022

Figure 22. Recombinant Human Growth Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 23. Global Recombinant Human Growth Hormone Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Figure 24. North America Recombinant Human Growth Hormone Sales Market Share by Country (2018-2029)

Figure 25. North America Recombinant Human Growth Hormone Revenue Market Share by Country (2018-2029)

Figure 26. United States Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 27. Canada Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 28. Europe Recombinant Human Growth Hormone Sales Market Share by Country (2018-2029)

Figure 29. Europe Recombinant Human Growth Hormone Revenue Market Share by Country (2018-2029)

Figure 30. Germany Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 31. France Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 32. U.K. Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 33. Italy Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 34. Russia Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 35. Asia Pacific Recombinant Human Growth Hormone Sales Market Share by Region (2018-2029)

Figure 36. Asia Pacific Recombinant Human Growth Hormone Revenue Market Share by Region (2018-2029)

Figure 37. China Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 38. Japan Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 39. South Korea Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 40. India Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 41. Australia Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 42. China Taiwan Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 43. Southeast Asia Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 44. Latin America Recombinant Human Growth Hormone Sales Market Share by Country (2018-2029)

Figure 45. Latin America Recombinant Human Growth Hormone Revenue Market Share by Country (2018-2029)

Figure 46. Mexico Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 47. Brazil Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 48. Argentina Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 49. Middle East & Africa Recombinant Human Growth Hormone Sales Market Share by Country (2018-2029)

Figure 50. Middle East & Africa Recombinant Human Growth Hormone Revenue Market Share by Country (2018-2029)

Figure 51. Turkey Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 52. Saudi Arabia Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 53. UAE Recombinant Human Growth Hormone Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 54. Global Sales Market Share of Recombinant Human Growth Hormone by Type (2018-2029)

Figure 55. Global Revenue Market Share of Recombinant Human Growth Hormone by Type (2018-2029)

Figure 56. Global Recombinant Human Growth Hormone Price (US$/Unit) by Type (2018-2029)

Figure 57. Global Sales Market Share of Recombinant Human Growth Hormone by Application (2018-2029)

Figure 58. Global Revenue Market Share of Recombinant Human Growth Hormone by Application (2018-2029)

Figure 59. Global Recombinant Human Growth Hormone Price (US$/Unit) by Application (2018-2029)

Figure 60. Recombinant Human Growth Hormone Value Chain

Figure 61. Recombinant Human Growth Hormone Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Recombinant Human Growth Hormone Market Research Report 2023

Published Date: November 2023

Report Code: QYRE-Auto-14N3693

Global Recombinant Human Growth Hormone Market Research Report 2023

FEATURED COMPANIES

Recombinant Human Growth Hormone Market Size

Recombinant Human Growth Hormone Market

Report Scope

Scope of Recombinant Human Growth Hormone Market Report

FAQ for this report

How fast is Recombinant Human Growth Hormone Market growing?

What is the Recombinant Human Growth Hormone Market size in 2029?

Who are the main players in the Recombinant Human Growth Hormone Market report?

What are the Application segmentation covered in the Recombinant Human Growth Hormone Market report?

What are the Type segmentation covered in the Recombinant Human Growth Hormone Market report?

FEATURED COMPANIES

Single User, Electronic (PDF)